The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2025

Filed:

Jul. 08, 2020
Applicant:

Purdue Research Foundation, West Lafayette, IN (US);

Inventors:

Philip Stewart Low, West Lafayette, IN (US);

Fenghua Zhang, West Lafayette, IN (US);

John Victor Napoleon, West Lafayette, IN (US);

Assignee:

Purdue Research Foundation, West Lafayette, IN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/55 (2017.01); A61K 45/06 (2006.01); A61K 47/54 (2017.01); A61K 47/60 (2017.01); A61P 11/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/55 (2017.08); A61K 45/06 (2013.01); A61K 47/545 (2017.08); A61K 47/60 (2017.08); A61P 11/00 (2018.01);
Abstract

Compounds, pharmaceutical compositions and methods are provided for reprogramming M2-like macrophages to M1-like macrophages, which reverses the antifibrotic to profibrotic shift observed during the course of fibrotic diseases and certain cancers. The compounds comprise an immune modulator that targets a pattern recognition receptor of a cell and are specific to the cells of interest through the incorporation of a targeting moiety (e.g., folate or a functional fragment or analog thereof). Releasable and/or non-releasable linkers can be included and engineered to facilitate the optimal delivery of the immune modulator. The compounds and compositions can be employed in one or more methods of treatment for fibrotic diseases and/or cancers.


Find Patent Forward Citations

Low, Philip. (2025). Compounds and methods for the treatment and prevention of fibrotic disease states and cancer (U.S. Patent No. 12397059). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12397059

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…